Stereotaxis (STXS) Other Working Capital Changes (2010 - 2026)
Stereotaxis (STXS) posted quarterly Other Working Capital Changes of $834000.0 for Q1 2026, down 15.93% year-over-year from $992000.0 in Q1 2025, and up 143.53% quarter-over-quarter from -$1.9 million in Q4 2025.
Stereotaxis (STXS) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Other Working Capital Changes for 10 consecutive years, with $834000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 15.93% year-over-year to $834000.0; the TTM figure through Mar 2026 stood at -$2.8 million (down 219.44% YoY), while the FY2025 annual figure was -$2.6 million, down 559.58% from the prior year.
- Other Working Capital Changes advanced to $834000.0 in Q1 2026 per STXS's latest filing, from -$1.9 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.1 million in Q3 2025 and bottomed at -$1.3 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged -$32176.5 across 5 years, with a median of -$3000.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 736.36% — and 2024, when it surged 1643.75%.
- Stereotaxis' Other Working Capital Changes stood at -$210000.0 in 2022, then soared by 145.71% to $96000.0 in 2023, then soared by 1643.75% to $1.7 million in 2024, then plunged by 214.46% to -$1.9 million in 2025, then jumped by 143.53% to $834000.0 in 2026.
- Business Quant data shows STXS's Other Working Capital Changes at $834000.0 in Q1 2026, -$1.9 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 599,000.00 |
| Mar 31, 2026 | 599,000.00 |
| Mar 31, 2026 | 599,000.00 |
| Dec 31, 2025 | -1.32 Mn |
| Dec 31, 2025 | -1.32 Mn |
| Dec 31, 2025 | -1.32 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | -153,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Mar 31, 2025 | -760,000.00 |
| Mar 31, 2025 | -760,000.00 |
| Mar 31, 2025 | -760,000.00 |
| Dec 31, 2024 | -31,000.00 |
| Dec 31, 2024 | -31,000.00 |
| Dec 31, 2024 | -31,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |